Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Renocel 4000IU Injection: Elevating Red Blood Cell Production for Optimal Health
Introduction:
Renocel 4000IU Injection stands as a therapeutic ally, invigorating the bone marrow to enhance the production of red blood cells. Primarily utilized for the treatment of anemia stemming from kidney disease, this medication also plays a vital role in addressing anemia induced by cancer chemotherapy and medication-related anemia in HIV treatment. The dosage is contingent on body weight and the underlying cause of anemia. Proper storage in a refrigerator is necessary, but the utilization should be at room temperature.
Uses of Renocel 4000IU Injection: A Comprehensive Approach to Anemia
Treatment of Anemia due to Chronic Kidney Disease:
Renocel 4000IU Injection, a synthetic protein, facilitates the bone marrow in producing more red blood cells. It effectively addresses anemia associated with kidney disease in both adults and children undergoing dialysis. Administered post-dialysis by a healthcare professional, the injection reduces weakness and fatigue associated with anemia.
Treatment of Anemia due to Cancer Chemotherapy:
Anemia, characterized by a deficiency of red blood cells, is combated by Renocel 4000IU Injection through the stimulation of the bone marrow to produce more red blood cells. This is particularly crucial when the standard human form of the protein is diminished during chemotherapy for certain cancers. The injection minimizes the need for blood transfusions, potentially enhanced by iron supplements for improved efficacy.
Benefits of Renocel 4000IU Injection: Illuminating the Path to Health
In Treatment of Anemia due to Chronic Kidney Disease:
Offering a synthetic boost to the production of red blood cells, Renocel 4000IU Injection effectively manages anemia arising from kidney disease. Administered post-dialysis by a healthcare professional, it mitigates the fatigue and weakness associated with anemia.
In Treatment of Anemia due to Cancer Chemotherapy:
Operating as an erythropoiesis-stimulating agent (ESA), Renocel 4000IU Injection stimulates the bone marrow to produce more red blood cells. This proves instrumental during chemotherapy, reducing the reliance on blood transfusions and potentially enhanced by iron supplements for improved efficacy.
Mechanism of Action: Fostering Red Blood Cell Production
Renocel 4000IU Injection, classified as an erythropoiesis-stimulating agent (ESA), stimulates the bone marrow to increase the production of red blood cells. This targeted mechanism addresses anemia, ensuring a more robust and balanced red blood cell count.